Table 2.
Procedural details for the AKI and non-AKI groups.
| Characteristic | Non-AKI (N = 180) | AKI (N = 139) | p value | |
| CAG, n% | 161 (89.4%) | 110 (79.1%) | 0.017 | |
| PCI, n% | 156 (86.7%) | 107 (77%) | 0.035 | |
| Emergency PCI, n% | 63 (39.1%) | 21 (19.3%) | 0.001 | |
| Number of stents | 2.0 (1.0 to 2.0) | 2.0 (1.0 to 2.0) | 0.872 | |
| Culprit artery, n% | 0.358 | |||
| LM | 26 (15.7%) | 20 (16.4%) | ||
| LAD | 83 (50.9%) | 68 (55.8%) | ||
| LCX | 13 (8.0%) | 12 (9.8%) | ||
| RCA | 41 (25.2%) | 22 (18.0%) | ||
| Number of lesion vessels | 0.334 | |||
| 1 | 28 (17.8%) | 13 (12.1%) | ||
| 2 | 42 (26.8%) | 26 (24.3%) | ||
| 3 | 87 (55.4%) | 68 (63.6%) | ||
| CTO, n% | 41 (26.1%) | 31 (28.4%) | 0.780 | |
| Contrast volume, mL | 160.0 (140.0 to 200.0) | 150.0 (130.0 to 220.0) | 0.824 | |
| Heparin, IU | 7000 (5775, 8500) | 7230 (6000, 9050) | 0.248 | |
| Bivalirudin, n% | 75 (49%) | 44 (40.7%) | 0.232 | |
| Tirofiban, n% | 46 (29.3%) | 22 (20.2%) | 0.125 | |
| Duration of PCI, min | 40.0 (30.0 to 60.0) | 40.0 (25.0 to 65.0) | 0.984 | |
| Duration of IABP use, days | 5.0 (4.0 to 6.0) | 7.0 (5.0 to 11.0) | 0.001 | |
AKI, acute kidney injury; CAG, coronary angiography; PCI, percutaneous coronary intervention; LM, left main coronary artery; LAD, left anterior descending coronary artery; LCX, left circumflex artery; RCA, right coronary artery; CTO, chronic total occlusion; IABP, intra-aortic balloon pump.